Abstract
There are diverse causes of lesions or diseases of the peripheral or central nervous systems that can lead to neuropathic pain. The pathophysiology covers a wide range and is largely ill-defined. Patients with neuropathic pain often present with symptoms of allodynia, hyperalgesia, and paresthesias and describe their pain as tingling, pins and needles, burning, stabbing, and aching. Treatment typically involves a multimodal approach, including nonpharmacological (physical and cognitive behavioral therapies), pharmacological, interventional, and, rarely, surgical therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Treede R-D, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70:1630–5.
Hurley RW, Goldstein HV, Rathmell JP. Chapter 55: painful peripheral neuropathies. In: Benzon HT, Raja SN, Liu SS, et al., editors. Essential of pain medicine. 3rd ed. St. Louis: Elsevier/Saunders; 2011. p. 386–94.
Geber C, Baumgartner U, Schwab R, et al. Revised definition of neuropathic pain and its grading system: an open case series illustrating its use in clinical practice. Am J Med. 2009;122:S3–S12.
Hall GC, Carroll D, Parry D, et al. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain. 2006;122:156–2.
Turk DC. Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain. Clin J Pain. 2002;18:355–65.
Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143–9.
Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.
Callaghan BC, Hur J, Feldman EL. Diabetic neuropathy: one disease or two? Curr Opin Neurol. 2012;25(2):536–41.
Kaye AD, Argoff CE. Chapter 1: Postherpetic neuralgia. In: Kaye AD, Shah RV, editors. Case studies in pain management. Cambridge, UK: Cambridge University Press; 2015. p. 1–15.
Berger A, Dukes EM, Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain. 2004;5:143–9.
Stookey B, Ransohoff J. Trigeminal neuralgia: its history and treatment. Springfield: Charles C. Thomas; 1959.
Eboli P, Stone JL, Audin S, et al. Historical characterization of trigeminal neuralgia. Neurosurgery. 2009;64:1183–7.
Tenser R. Trigeminal neuralgia: mechanisms of treatment. Neurology. 1998;51:17–9.
Internet Stroke Center. 2006. Stroke statistics http://www.strokecenter.org/patients/about-stroke/stroke-statistics/. Accessed 7 Jan 2017.
Kim JS. Post-stroke pain. Expert Rev Neurother. 2009;9(5):711–21.
Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet. 1999;353:1959–64.
Fields H, Rowbotham M. Multiple mechanisms of neuropathic pain: a clinical perspective. Seattle: IASP Press; 1994.
Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–8.
Galer BS. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 1995;45:S17–25; discussion S35–6
Calcutt NA. Potential mechanisms of neuropathic pain in diabetes. Int Rev Neurobiol. 2002;50:205–28.
Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, editors. Textbook of pain. Edinburgh, UK: Churchill-Livingstone; 1994. p. 243–57.
Horowitz SH. The diagnostic workup of patients with neuropathic pain. Med Clin North Am. 2007;91:21–30.
Haanpaa ML, Backonja MM, Bennett MI, et al. Assessment of neuropathic pain in primary care. Am J Med. 2009;122:S13–21.
Doulatram G, Raj T. Chapter 8: Diabetic neuropathy. In: Kaye AD, Shah RV, editors. Case studies in pain management. Cambridge, UK: Cambridge University Press; 2015. p. 52–63.
Feng Y, Schlosser FJ, Supio BE. The Semmes Weinstein monofilament examination as a screen tool for diabetic peripheral neuropathy. J Vasc Surg. 2009;50(3):675–82.
Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Atlanta: Centers for Disease Control and Prevention; 2011.
Tesfaye S, Vileikyte L, Rayman G, et al. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev. 2011;27(7):629–38.
Shakher J, Stevens MJ. Update on the management of diabetic polyneuropathies. Diabetes Metab Syndr Obes. 2011;4:289–305.
Chen N, Li Q, Yang J, et al. Antiviral treatment for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2014. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD006866.pub3/abstract;jsessionid=E37027B3628E2E1AFF4793F715A78032.f04t03.
Han Y, Zhang J, Chen N, et al. Corticosteroids for preventing postherpetic neuralgia. Cochrane Database Syst Rev. 2013. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005582.pub4/abstract
Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia: an evidence-based review. Neurology. 2008;71:1183–90.
Maury J, Kaye AD, Gould HJ. Chapter 44: Pain management in trigeminal neuralgia. In: Kaye AD, Shah RV, editors. Case studies in pain management. Cambridge, UK: Cambridge University Press; 2015. p. 316–23.
Sindrup S, Jensen T. Pharmacotherapy of trigeminal neuralgia. Clin J Pain. 2002;18:22–7.
Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol. 2009;8(9):857–68.
Leijon G, Boivie J. Central post-stroke pain: a controlled trial of amitriptyline and carbamazepine. Pain. 1989;36(1):27–36.
Kumar B, Kalita J, Kumar G, et al. Central poststroke pain: a review of the pathophysiology and treatment. Anesth Analg. 2009;108(5):1645–57.
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3):S2–S15.
McMahon SB, Lewin GR, Wall PD. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol. 1993;3(4):602–10.
Finnerup NB, Attal N, Haroutounian S, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–73.
Jongen JL, Hans G, Benzon HT, et al. Neuropathic pain and pharmacological treatment. Pain Pract. 2014;14(3):283–95.
Gilron I, Chapparro LE, Tu D, et al. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial. Pain. 2016;157:1532–40.
Becker WJ, Ablett DP, Harris CJ, et al. Long term treatment of intractable reflex sympathetic dystrophy with intrathecal morphine. Can J Neurol Sci. 1995;22:153–9.
Wu CL, Marsh A, Dworkin RH. The role of sympathetic nerve blocks in herpes zoster and postherpetic neuralgia. Pain. 2000;87:121–9.
Simpson EL, Duenas A, Holmes MW, et al. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technol Assess. 2009;13:1–154.
Grabow TSM, Tella PKM, Raja SNM. Spinal cord stimulation for complex regional pain syndrome: an evidence-based medicine review of the literature. Clin J Pain. 2003;19:371–83.
Kemler M, de Vet C, Barendse G, et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg. 2008;108:292–8.
Taylor RS, Buyten JPV, Buchser E. Spinal cord stimulation for complex regional pain syndrome: a systematic review of the clinical and cost-effectiveness literature and assessment of prognostic factors. Eur J Pain. 2006;10:91–101.
Liem L, Russo M, Huygen F, et al. One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Neuromodulation. 2014;18:41–9.
Slangen R, Schaper NC, Faber CG, et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care. 2014;37(11):3016–24.
de Vos CC, Meier K, Zaalberg PB, et al. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain. 2014;155(11):2426–31.
Slangen R, Faber CG, Schaper NC, et al. A trial-based economic evaluation comparing spinal cord stimulation with best medical treatment in painful diabetic peripheral neuropathy. J Pain. 2017;18(4):405–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Eckman, T., Cheng, J. (2019). Neuropathic Pain. In: Khelemsky, Y., Malhotra, A., Gritsenko, K. (eds) Academic Pain Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-18005-8_42
Download citation
DOI: https://doi.org/10.1007/978-3-030-18005-8_42
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-18004-1
Online ISBN: 978-3-030-18005-8
eBook Packages: MedicineMedicine (R0)